Atsuko Watarai

606 total citations
20 papers, 511 citations indexed

About

Atsuko Watarai is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Atsuko Watarai has authored 20 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Epidemiology and 5 papers in Physiology. Recurrent topics in Atsuko Watarai's work include Pain Mechanisms and Treatments (3 papers), Botulinum Toxin and Related Neurological Disorders (3 papers) and Alcohol Consumption and Health Effects (3 papers). Atsuko Watarai is often cited by papers focused on Pain Mechanisms and Treatments (3 papers), Botulinum Toxin and Related Neurological Disorders (3 papers) and Alcohol Consumption and Health Effects (3 papers). Atsuko Watarai collaborates with scholars based in Japan, Australia and United States. Atsuko Watarai's co-authors include Jiro Nakamura, Hideki Kamiya, Eitaro Nakashima, Yutaka Oiso, Yoji Hamada, Keiko Naruse, Yoshiki Ohba, Masaki Kondo, Koichi Kato and Yoshiro Kato and has published in prestigious journals such as Diabetes, Biochemical and Biophysical Research Communications and Diabetologia.

In The Last Decade

Atsuko Watarai

20 papers receiving 496 citations

Peers

Atsuko Watarai
Atsuko Watarai
Citations per year, relative to Atsuko Watarai Atsuko Watarai (= 1×) peers Weikai Hou

Countries citing papers authored by Atsuko Watarai

Since Specialization
Citations

This map shows the geographic impact of Atsuko Watarai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsuko Watarai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsuko Watarai more than expected).

Fields of papers citing papers by Atsuko Watarai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsuko Watarai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsuko Watarai. The network helps show where Atsuko Watarai may publish in the future.

Co-authorship network of co-authors of Atsuko Watarai

This figure shows the co-authorship network connecting the top 25 collaborators of Atsuko Watarai. A scholar is included among the top collaborators of Atsuko Watarai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsuko Watarai. Atsuko Watarai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kamiya, Hideki, Tatsuhito Himeno, Atsuko Watarai, et al.. (2024). Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10). Journal of Diabetes Investigation. 15(2). 247–253. 3 indexed citations
3.
Yoshioka, Kentaro, Kazuhiko Hayashi, Yuko Shimizu, et al.. (2022). Prevalence of nonalcoholic fatty liver disease and its association with age in patients with type 2 diabetes mellitus. World Journal of Hepatology. 14(6). 1226–1234. 10 indexed citations
4.
Omori, Keiko, Takahiko Kawamura, Atsuko Watarai, et al.. (2017). Effect of re-coaching on self-injection of insulin in older diabetic patients – Impact of cognitive impairment. Diabetes Research and Clinical Practice. 130. 34–42. 6 indexed citations
5.
Kawamura, Takahiko, Toshitaka Umemura, Hiroyuki Umegaki, et al.. (2016). Factors Associated with Changes in Brain Atrophy during a Three-Year Observation in Elderly Diabetic Patients: Effect of Renal Impairment on Hippocampal Atrophy. Dementia and Geriatric Cognitive Disorders Extra. 6(1). 55–67. 11 indexed citations
6.
Kato, Yoshiro, Hideki Kamiya, Naoki Koide, et al.. (2015). Irbesartan attenuates production of high-mobility group box 1 in response to lipopolysaccharide via downregulation of interferon-β production. International Immunopharmacology. 26(1). 97–102. 4 indexed citations
7.
Hayami, Tomohide, Yoshiro Kato, Hideki Kamiya, et al.. (2015). Case of ketoacidosis by a sodium‐glucose cotransporter 2 inhibitor in a diabetic patient with a low‐carbohydrate diet. Journal of Diabetes Investigation. 6(5). 587–590. 94 indexed citations
8.
Kato, Yoshiro, Hideki Kamiya, Naoki Koide, et al.. (2014). Spironolactone inhibits production of proinflammatory mediators in response to lipopolysaccharideviainactivation of nuclear factor-κB. Immunopharmacology and Immunotoxicology. 36(3). 237–241. 20 indexed citations
9.
Kondo, Masaki, Hideki Kamiya, Tatsuhito Himeno, et al.. (2014). Therapeutic efficacy of bone marrow‐derived mononuclear cells in diabetic polyneuropathy is impaired with aging or diabetes. Journal of Diabetes Investigation. 6(2). 140–149. 17 indexed citations
10.
Kawamura, Takahiko, Toshitaka Umemura, Hiroyuki Umegaki, et al.. (2014). Effect of renal impairment on cognitive function during a 3‐year follow up in elderly patients with type 2 diabetes: Association with microinflammation. Journal of Diabetes Investigation. 5(5). 597–605. 18 indexed citations
11.
Nagasawa, Kazumichi, et al.. (2013). Significant modulation of the hepatic proteome induced by exposure to low temperature inXenopus laevis. Biology Open. 2(10). 1057–1069. 18 indexed citations
12.
Kawamura, Takahiko, Toshitaka Umemura, Hiroyuki Umegaki, et al.. (2011). Does cerebral small vessel disease predict future decline of cognitive function in elderly people with type 2 diabetes?. Diabetes Research and Clinical Practice. 94(1). 91–99. 47 indexed citations
13.
Nakashima, Eitaro, Atsuko Watarai, Yoji Hamada, et al.. (2010). Association of resistin polymorphism, its serum levels and prevalence of stroke in Japanese type 2 diabetic patients. Journal of Diabetes Investigation. 1(4). 154–158. 13 indexed citations
14.
Nakashima, Eitaro, Atsuko Watarai, Yoji Hamada, et al.. (2009). Polymorphism in resistin promoter region at −420 determines the serum resistin levels and may be a risk marker of stroke in Japanese type 2 diabetic patients. Diabetes Research and Clinical Practice. 84(2). 179–186. 41 indexed citations
15.
Nakamura, Jiro, Weiguo Li, Atsuko Watarai, et al.. (2007). Metformin prevents methylglyoxal-induced apoptosis of mouse Schwann cells. Biochemical and Biophysical Research Communications. 357(1). 270–275. 54 indexed citations
16.
Watarai, Atsuko, Eitaro Nakashima, Yuichi Hamada, et al.. (2006). Aldose reductase gene is associated with diabetic macroangiopathy in Japanese Type 2 diabetic patients. Diabetic Medicine. 23(8). 894–899. 22 indexed citations
17.
Kamiya, Hideki, Keiko Naruse, Naoichi Horio, et al.. (2006). Effects of Basic Fibroblast Growth Factor on Experimental Diabetic Neuropathy in Rats. Diabetes. 55(5). 1470–1477. 55 indexed citations
18.
Kobayashi, Yukio, Keiko Naruse, Yuichi Hamada, et al.. (2005). Human proinsulin C-peptide prevents proliferation of rat aortic smooth muscle cells cultured in high-glucose conditions. Diabetologia. 48(11). 2396–2401. 39 indexed citations
19.
Ohba, Yoshiki, et al.. (1979). Reaction of Formaldehyde with Calf-Thymus Nucleohistone. European Journal of Biochemistry. 100(1). 285–293. 31 indexed citations
20.
Shishido, Kazuo, et al.. (1975). Action of bleomycin on the bacteriophage T7 infection.. The Journal of Antibiotics. 28(9). 676–680. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026